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Abstract Protein kinase C (PKC) is involved in a variety of 
cellular responses, such as the expression and secretion of IL-2, 
the regulation of cytotoxic killing and cell proliferation. It is 
known that these immune functions are altered with aging. Here, 
we show that anti-CD3-triggered T cell proliferation is signifi- 
cantly decreased with aging and that H7, an inhibitor of PKC, 
impairs the anti-CD3-induced T cell proliferation in a differential 
manner, lymphocytes of healthy young subjects being more sensi- 
tive to the PKC inhibitor than those of elderly subjects. We 
examined (Western blot) the presence and the cellular distribu- 
tion of PKC isozymes in T lymphocytes of healthy young and 
elderly subjects in the resting state and after anti-CD3 mAb 
stimulation using antibodies directed against PKC 6,/3, 8, e and 
isoforms in the cytosol and the plasma membrane fractions. 
These five PKC isotypes were present in human T cells of young 
and elderly subjects. However, their distribution between the cy- 
tosolic and membrane fractions varied according to the isozymes 
and the age of the subjects. In resting lymphocytes of young 
subjects, all the PKC isozymes were found in the cytosolic frac- 
tion, except PKC-~. In resting lymphocytes of elderly subjects 
PKC-~ and -e were almost equally distributed between the cy- 
tosolic and the membrane fractions, whereas PKC- ,  and -~ were 
mainly found in the membrane fraction and PKC-/3 was almost 
exclusively located in the cytosolic fraction. The translocation of 
PKC-c~, -/3, -~ and -E could be observed under anti-CD3 mAb 
stimulation in lymphocytes of young subjects, while in the case 
of elderly subjects only the PKC ]3 isoform was translocated. Our 
results suggest hat the decreased availability of cytosolic PKC 
may contribute to the diminished PKC-dependent responses to 
CD3-triggered stimulation of human T lymphocytes with aging. 
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1. Introduction 
The specificity of the immune response is determined by the 
interaction between the T cell antigen receptor (TcR) and its 
cognate antigen. The TcR is coupled to the cytoplasmic non- 
receptor tyrosine-protein kinases by the cytoplasmic tails of the 
TcR-associated CD3 subunits. The signalling events down- 
stream of protein-tyrosine phosphorylation following T cell 
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receptor stimulation include the activation of the phosphatidy- 
linositol pathway, p21 ras and several serine/threonine protein 
kinases. The transmission of signals to the nucleus is proposed 
to involve a protein kinase cascade, including Raf-1, mitogen- 
activated (MAP) kinase and MAP kinase kinase. At least two 
intracellular pathways for regulation of this cytoplasmic pro- 
tein kinase cascade coexists in T cells; one mediated by p21 ras 
and the other by protein kinases C [1]. 
Stimulation of the TcR increases phospholipase C activity 
and that results in hydrolysis of Ptdlns (4,5)P2 yielding the 
second messengers InsP3 and 1,2-diacylglycerol (DAG). DAG 
is responsible for the activation of some protein kinase C (PKC) 
isozymes. PKC has been implicated in the regulation of a vari- 
ety of cellular processes, including proliferation, differentiation 
and release of hormones, lymphokines and neurotransmitters 
[2,3]. Recent studies have shown that several cytokine gene 
expression is strictly dependent on a T cell-specific protein 
complex, called nuclear factor of activated T cells (NF-AT) and 
the de novo synthesis of NF-ATn is absolutely dependent on 
the activation of PKC stimulated via T cell antigen receptor 
and/or phorbol esters [4-6]. 
Molecular cloning had so far revealed that PKC consists of 
a large family of at least 12 different members. They are divided 
in three major groups: the calcium-dependent or conventional 
protein kinases (cPKC) consisting of the ~, ill, /32 and 9, 
isoforms; the calcium-independent or novel protein kinases 
(nPKC) consisting of the 8, e, r/, 0 and ¢t isoforms; and the 
atypical protein kinases (aPKC) consisting of the (, t and 2 
isoforms [2,7]. The members of the PKC family are dependent 
on phosphatidylserine, but show clearly different requirements 
for other modulators. On the one hand, cPKC are activated by 
Ca 2+ and DAG and this activation is further enhanced by cis- 
polyunsaturated fatty acids and lysophosphatidylcholine. On 
the other hand, nPKC respond to DAG and phorbol esters and 
the e isoform may also be activated by cis-unsaturated fatty 
acids. The ~ and e PKC isozymes are the best-characterized 
member of this group and they exist in a phosphorylated form. 
In contrast, aPKC are not activated by DAG. PKC-( does not 
respond to PMA, but it requires phosphatidylserine and is 
activated by cis-unsaturated fatty acids [8,9]. In T lymphocytes, 
all subspecies of PKC, with the exception of PKC-?', have been 
detected [2,10]. Recent results have shown that fl PKC is the 
dominant isozyme in T cells [11,12]. 
Aging is accompanied by changes in the immune system, 
including impairment of delayed type hypersensitivity and 
other T cell functions [13,14]. Although the mechanisms under- 
lying these age-dependent defects in T cell functions are not 
completely elucidated, alterations in signal transduction may 
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contribute to the observed efects [15-18]. Several functions of 
T cells that either partially depend on PKC activity or are 
regulated by the activation of PKC exhibit abnormalities dur- 
ing aging [19,20]. For instance, T cells from elderly subjects 
stimulated through the TcR/CD3 complex show diminished 
production of IL2 and a decrease in IL2 receptor expression as 
well as reduced activation of the AP1 and NFxB transcription 
factors [21,22]. 
The effects of aging on the activation of PKC isozymes in 
human lymphocytes are largely unknown. One recent study has 
shown that the level of PKC-~ was decreased in T lymphocytes 
of elderly subjects while that of PKC-fl was unchanged [23]. The 
aim of the present study was to investigate the presence of PKC 
isozymes in human T lymphocytes of elderly subjects and to 
assess their distribution between the cytosol and the membrane 
fractions in the resting state and their translocating capacity 
after stimulation with an anti-CD3 mAb. 
2. Materials and methods 
2.1. Materials 
Chemicals for sodium dodecyl sulfate-polyacrylamide gel lectropho- 
resis (SDS-PAGE) were purchased from Bio-Rad (Richmond, CA). 
Protease inhibitors, phosphatase inhibitors, PMA, H7 and anti-CD3 
(clone C-7048 derived from UCHT1) were obtained from Sigma (St 
Louis, MO). Polyclonal, affinity-purified antibodies against PKC 
isoforms (~, fl, ~, e and ~ and RPMI 1640 culture medium were 
obtained from Gibco BRL (Grand Island, NY). The enhanced chemilu- 
minescence kit (ECL) Western blot detection system, antirabbit Ig, 
HRP and [3H]thymidine were purchased from Amersham (Arlington 
Heights, IL). DEAE cellulose (Whatman) was obtained from Mandel 
Scientific (Montreal, Canada). 
2.2. Subjects 
The 16 elderly subjects participating to this study ranged from 65 to 
87 years old (mean 78 years) and included 5 women. All subjects were 
ambulatory and in good health, satisfying the inclusion criteria of the 
SENIEUR protocol for immunologic nvestigation of human elderly 
subjects. The 15 young subjects were healthy volunteers having a mean 
age of 35 years and included 5 women. All subjects gave their informed 
consent. 
2.3. Lymphocyte separation 
Heparinized blood was diluted 2-fold with RPMI 1640 medium con- 
taining 2% fetal bovine serum. Lymphocytes were isolated from periph- 
eral blood samples by Ficoll-Hypaque density sedimentation using pro- 
cedures previously described [24]. Monocytes and B cells were removed 
by adhesion to plastic dishes and to nylon wool. The resulting highly 
enriched T cell population consisted of greater than 97% OKT3 (CD3)- 
positive cells with less than 1.0% surface IgM, CD 16 or OKM5-positive 
cells. Lymphocytes were phenotyped as CD3+ cells by incubating them 
for 30 min with anti-CD3 mAb (Sigma) and washed twice in PBS. Cells 
were then exposed to a fluorescein isothiocyanate (FITC)-conjugated 
goat antimouse IgG for 30 rain on ice and washed twice with PBS. 
Fluorescence analysis was performed by flow cytometry on a FACScan 
instrument (Beckton Dickinson). At least 10,000 cells were analysed in 
each experiment [24]. 
2.4. Cell culture and proliferation assays 
Peripheral blood lymphocytes (PBL) were cultured in a final volume 
of 200/~1 of complete media in triplicates in 96-well fiat-bottomed 
microculture plates (Corning, NY). Their proliferative response was 
measured by exposing the cells to the anti-CD3 mAb. Optimal culture 
conditions were as determined previously [25], 2 x 105cells/well, 3 days 
for [3H]thymidine incorporation, 500 nM of PMA, 100/tM for H7 and 
finally 5 ~tg/ml for anti-CD3 mAb. When used, H7 was present during 
the 72-h culture. Cell proliferation assays were performed by addition 
of 0.25/ICi/well of [3H]thymidine 4 h before harvest. The [3H]thymidine 
uptake was determined ina standard liquid scintillation counter (Pack- 
ard, USA). 
2.5. PKC isolation and immunoblot analysis 
T lymphocytes (5x 10 7 cells/ml) were exposed to anti-CD3 mAb (5 
/lg/ml) for 10 min and a purified F(ab')2 fragments of sheep antimouse 
IgG was added (8/.tg/ml) for 5 min. Cytosolic and particulate fractions 
were prepared in lysis buffer (containing Tris 20 mM, pH 7.5, sucrose 
330 mM, EDTA 2 mM, EGTA 0.5 mM, PMSF 2 mM, DTT 10 mM, 
aprotinin 1 mg/ml, benzamidine 10 mM). The cells were disrupted by 
passage through a26-gauge needle and were centrifuged at100,000 x g. 
Cytosolic and NP-40 solubilized particulate PKC were partially puri- 
fied on a DE52 ion-exchange column (Whatman) and eluted with 200 
/A of NaC1 (80 mM)-containing lysis buffer. For immunoblot analysis, 
PKC-containing fractions were concentrated using Centricon 30 micro- 
concentrators (Amicon). The protein concentration was measured by 
the method of Lowry et al. [26]. Equal amounts of cytosol- and mem- 
brane-purified PKC were loaded in each lane (1 pg protein) and frac- 
tionated by SDS-PAGE on 10% acrylamide gels and electrophoretically 
transferred to nitrocellulose membranes. The membranes were incu- 
bated with the respective polyclonal anti-PKC isozymes antibodies 
(dilution 1:1000). The secondary antibody was an antirabbit HRP 
conjugate (dilution 1 : 1000). Immunoblots were developed by chemilu- 
minescence as described previously [15]. The relative immunostaining 
pattern for individual isozymes was quantitated by scanning densitom- 
etry. The scanning was performed with a hand-held instrument (Light- 
ning Scanner 256) and data analysed with the Scan Analysis software 
(Macintosh microcomputer). 
2.6. Statistical analyses 
Student's t test was used as routine statistical test with statistical 
significance set at P < 0.05. 
3. Results 
3.1. Proliferation assays 
The functional activity of lymphocytes was assayed by their 
capacity to proliferate in response to an anti-CD3 mAb (Table 
1). The basal proliferative activity of  lymphocytes of elderly 
subjects did not differ significantly from that of young subjects 
with respect o the amount of [3H]thymidine taken up by the 
cells. However, exposure of the cells to the anti-CD3 mAb 
resulted in a large increase in radioactive counts and a prolifer- 
ative index of 46 + 13 in the case of young subjects. In marked 
contrast, the proliferative index of lymphocytes from elderly 
subjects was approximately one-half of that found for young 
subjects (P < 0.02). Similar observations were made in the case 
of PMA-induced proliferation of lymphocytes (P < 0.05). In a 
second set of  experiments he effect of H7, an inhibitor of PKC, 
was assessed on the basal proliferative response. Results show 
that H7 did not significantly influence the amount of [3H]thy- 
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Fig. 1. PKC ~ isoform immunoreactivity (Western blots) in the cytosol 
(C) and membrane (M) fractions of human T lymphocytes obtained 
from healthy young (n = 15), in the resting state (young anti-CD3-) 
and after anti-CD3 mAb stimulation (young anti-CD3+) and from 
elderly subjects (n = 16) in resting state (old anti-CD3-) and after 
anti-CD3 mAb stimulation (old anti-CD3+). PKC, partially purified 
from cytosolic and solubilized membrane fractions, was subjected to 
SDS-PAGE (1/tg of protein/lane). Proteins were transferred to nitrocel- 
lulose sheets and immunoblotted with an antibody specific for PKC-~. 
The arrow indicate the position of PKC-~. The numbers at the right 
represent the relative size of protein standards (section 2). Data are 
representative of 15 (young) and 16 (elderly) experiments, respectively. 
T. Fulop Jr. et al. IFEBS Letters 375 (1995) 69-74 71 
Young Old 
C M C M C M C M 
Fig. 2. PKC fl isoforrn immunoreactivity (Western blots) in the cytosol 
(C) and membrane (M) fractions of human T lymphocytes obtained 
from healthy oung, in the resting state (young anti-CD3-) and after 
anti-CD3 mAb stimulation (young anti-CD3+) and from elderly sub- 
jects in the resting state (old anti-CD3-) and after anti-CD3 mAb 
stimulation (old anti-CD3+). Experimental details are described in the 
legend of Fig. 1. Data are representative of 15 (young) and 16 (elderly) 
experiments, respectively. 
midine uptake in T lymphocytes from young or elderly individ- 
uals. However, it inhibited lymphocyte proliferation when cells 
had been stimulated by exposure to the anti-CD3 mAb. For 
instance, the proliferative index of T lymphocytes from young 
and elderly subjects decreased to the same level and that corre- 
sponded to an approximately 4-fold decrease in the case of cells 
from the young individuals and approximately 2-fold for the 
elderly subjects. 
We then investigated the presence and cellular distribution 
of various PKC isozymes in lymphocytes of young and elderly 
subjects at rest and after stimulation with an anti-CD3 mAb. 
3.2. PKC-c~ 
In the case of lymphocytes from young subjects, PKC-~ was 
nearly exclusively found in the cytosol, although a small 
amount was associated with the plasma membrane fraction 
(Fig. 1, young anti-CD3-). After stimulation with anti-CD3 
mAb almost the totality of the isozyme translocated to the 
membrane (Fig. 1, young anti-CD3+). In the case of lympho- 
cytes of elderly subjects, two typical situations were found. In 
one series (n = 7), the totality of PKC-~ was found associated 
with the membrane fraction in resting cells (Fig. 1, old anti- 
CD3-).  In the other series (n = 9), the distribution of PKC-ct 
was found in almost equal amounts in the cytosol and the 
plasma membrane fractions (Fig. 1, old anti-CD3-). Independ- 
ently of the distribution of PKC-~ in the resting state, no 
changes in PKC-~ distribution could be obtained after stimula- 
tion, suggesting that PKC-~ did not translocate (Fig. 1, old 
anti-CD3+) in the case of elderly subjects. The qualitative ob- 
servations made on immunoblots were confirmed by densitom- 
etric scanning (Table 2). 
3.3. PKC-~ 
In the resting state, PKC-fl was mainly found in the cytosol 
of lymphocytes of young subjects, but a small quantity was 
detectable in the membrane fraction (Fig. 2, young anti-CD3-). 
In lymphocytes of elderly subjects, the isozyme was found al- 
most exclusively in the cytosol (Fig. 2, old anti-CD3-). After 
stimulation, PKC-fl translocated to the plasma membrane in 
the case of lymphocytes from young (Fig. 2, young anti-CD3+) 
and elderly subjects, although a small quantity was still detect- 
able in the cytosol (Fig. 2, old anti-CD3+; Table 2). 
3.4. PKC-~5 
The major quantity of PKC-8 was found in the cytosol of 
resting lymphocytes of young subjects, but a small amount was 
also associated with the membrane fraction (Fig. 3, young anti- 
CD3-). An unidentified protein band of 50 kDa appeared in 
the cytosolic fraction of lymphocytes of young and elderly 
subjects, but this was not observed in the membrane fraction. 
After anti-CD3 mAb stimulation, most of the enzyme translo- 
cated to the membrane (Fig. 3, young anti-CD3+). PKC-~ was 
distributed in almost equal quantity in the cytosol and mem- 
brane fractions of resting lymphocytes of elderly subjects (Fig. 
3, old anti-CD3-). No translocation could be observed after 
anti-CD3 mAb stimulation (Fig. 3, old anti-CD3+). These ob- 
servations were confirmed by densitometric s anning (Table 2). 
3.5. PKC-e 
PKC-e appeared as two bands of Mr ~98 and -72 kDa that 
were found mainly in the cytosol of lymphocytes of young 
subjects (Fig. 4, young anti-CD3-). Cell stimulation with anti- 
CD3 mAb resulted in a decrease of PKC-e in the cytosol and 
an apparent translocation to the membrane fraction (Fig. 4, 
young anti-CD3+; Table 2). In the case of elderly subjects, 
PKC-e was almost equally distributed between the cytosol and 
the membrane fractions of resting lymphocytes (Fig. 4, old 
anti-CD3-) and no apparent changes could be observed after 
stimulation with the anti-CD3 mAb (Fig. 4, old antiCD3+). 
3.6. PKC-~ 
PKC-~" was mainly found in the membrane fraction of resting 
Table 1 
[3H]-Thymidine incorporation by lymphocytes of young and elderly subjects in 3-day cultures 
[aH]thymidine Proliferation 
incorporation (cpm) index 
Young Eldery Young Eldery P value 
(n = 15) (n = 16) (n = 15) (n = 16) 
Agents 
None 1921 + 155 2375 + 140 - 
Anti-CD3 88946 _+ 28818 47507 +_ 19089 46 + 13 20 + 8 0.02 
PMA 28342 + 4672 13896 + 6679 14 + 2 6 + 3 0.05 
H7 3813 + 1425 8609 + 4433 2 + 0.8 4 + 2 N.S. 
H7 + anti-CD3 25686 + 2136 24663 + 1942 13 + 2 10 + 1 N.S. 
Proliferation assays were set up as described in section 2. Results (cpm) are the mean + S.D. Values of elderly are compared with that of young: 
N.S.: not significant. Limit of significance s t at P < 0.05. The proliferation i dex corresponds to the ratio of label incorporation i  stimulated cultures 
[cpm]/unstimulated (control) [cpm]. 
72 T. Fulop Jr. et al./FEBS Letters 375 (1995) 6~74 
Young Old Young Old  
C M C M C M C M C M C M C M C M 
ontiCD3 - -p  K S"~ ~i i ~ i i +~ " i_ ;'t" I : 06- ontiCD~PKC --]i "['1 +l ~'-~ []ii --97--1|6.__66 
Fig. 3. PKC ~ isoform immunoreactivity (Western blots) in the cytosol 
(C) and membrane (M) fractions of human T lymphocytes obtained 
from healthy oung, m the resting state (young anti-CD3-) and after 
anti-CD3 mAb stimulation (young anti-CD3+) and from elderly sub- 
jects in the resting state (old anti-CD3-) and after anti-CD3 mAb 
stimulation (old anti-CD3+). Experimental details are described inthe 
legend of Fig. 1. Data are representative of 15 (young) and 16 (elderly) 
experiments, respectively. 
Fig. 4. PKC e isoform immunoreactivity (Western blots) in the cytosol 
(C) and membrane (M) fractions of human T lymphocytes obtained 
from healthy oung, in the resting state (young anti-CD3-) and after 
anti-CD3 mAb stimulation (young anti-CD3+) and from elderly sub- 
jects in the resting state (old anti-CD3-) and after anti-CD3 mAb 
stimulation (old anti-CD3+). Experimental details are described inthe 
legend of Fig. 1. Data are representative of 15 (young) and 16 (elderly) 
experiments, respectively. 
lymphocytes ofyoung subjects, with a smaller amount detected 
in the cytosol fraction (Fig. 5, young anti-CD3-). After stimu- 
lation with anti-CD3 mAb, essentially no changes in its distri- 
bution or even a slight increase in the cytosol could be observed 
(Fig. 5, young anti-CD3+; Table 2). In the case of elderly 
subjects, nearly all PKC-( was also found in the membrane 
fraction in resting lymphocytes (Fig. 5, old anti-CD3-). Stimu- 
lation with anti-CD3 mAb induced an apparent equal distribu- 
tion between the cytosol and membrane fractions of lympho- 
cytes of elderly subjects (Fig. 5, old anti-CD3+). However, the 
scanning data indicate that after anti-CD3 mAb stimulation 
PKC-( decreased in the membrane and increased in the cytosol 
(Table 2). 
4. Discussion 
PKC is involved in a variety of cellular esponses, uch as 
IL-2 expression, IL-2 secretion, regulation of cytotoxic killing 
and cellular proliferation [3,27]. These immune functions are 
altered with aging [13,19,20,28]. The role of various isoforms 
of PKC in cell activation and proliferation is under intense 
investigation [9], but there are only a limited number of reports 
concerning PKC isoforms expression in lymphocytes with 
aging [23,29] The goal of the present study was to examine PKC 
isozyme distribution i resting and in CD3-stimulated lympho- 
cytes of healthy elderly and young subjects. 
T cell proliferation in response to activation has been re- 
ported to decrease with aging in humans and in animal models 
[25,28]. The causes for this impairment of response have not 
been still completely identified. T cell activation is a complex 
phenomenon that involves a cascade of events that leads to 
gene activation and lymphocytes leaving the resting state to go 
through the cell cycle and to divide. A number of kinases are 
involved, including PKC [30]. When T cells from young and 
elderly subjects were exposed to an anti-CD3 mAb or PMA, 
both responded with a significant increase in label uptake with 
respect to basal evel, although the stimulation i dex in the case 
of lymphocytes from the young subjects was approximately 
twice that of the elderly subjects. Of significance, the sensitivity 
of the proliferative response to H7, an inhibitor of PKC, that 
can also affect other protein kinases, was markedly different 
with aging. Whereas, lymphocytes from both groups of donors 
showed a decreased proliferative response, the inhibitor 
brought he value of the stimulation i dex to the same level. In 
this connection, a dose-related inhibitory effect of H7 on the 
proliferation of T lymphocytes of young subjects has already 
been reported [30]. Our data suggest that PKC plays a more 
determinant role in T cell response in the case of young sub- 
jects. Presently, there is no obvious explanation for this phe- 
nomenon, but it can be hypothesized that the diminished sensi- 
tivity of T cells from elderly subjects to H7 arises from the fact 
that these T cells might already undergo a persistent activation 
of the transduction cascade for some still unknown reason. In 
earlier studies, we have shown that IP3 was increased in the 
Table 2 
Relative distribution i  arbitrary densitometry units for PKC isozymes in T lymphocytes of young and elderly subjects at resting state and after 
anti-CD3 mAb stimulation i  the cytosol and the membrane fractions 
PKC ~ PKC fl PKC 6 PKC e(p98) PKC g(p72) PKC g" 
Young Old Young Old Young Old Young Old Young Old Young Old 
Cytosol Resting 10 12 10 5 10 10 10 5 10 4 10 5 
Stimulated 1.5 24 2 1 3 14 1 7 1.5 8 17 15 
Membrane Resting 2.5 26 3 0.8 4 6 3 6 6 6 23 22 
Stimulated 17 21 10 4 14 7 4 7 5 9 24 16 
The numbers indicate the density of immunostaining relative to each PKC isozyme determined in the cytosol of lymphocytes from young subjects 
at resting state. An arbitrarily value of 10 was assigned in each case and other values of densitometry were assigned in a relative manner. 
Immunostained gels (Figs. 1-5) were scanned with a hand-held instrument and data analysed with the Scan Analysis oftware (Macintosh microcom- 
puter). 
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Fig. 5. PKC-( isoform immunoreactivity (Western blots) in the cytosol 
(C) and membrane (M) fractions of human T lymphocytes obtained 
from healthy oung, in the resting state (young anti-CD3-) and after 
anti-CD3 mAb stimulation (young anti-CD3+) and from elderly sub- 
jects in the resting state (old anti-CD3-) and after anti-CD3 mAb 
stimulation (old anti-CD3+). Experimental details are described inthe 
legend of Fig. 1. Data are representative of 15 (young) and 16 (elderly) 
experiments, respectively. 
resting lymphocytes of elderly subjects, while its formation 
under stimulation was decreased [24]. Furthermore, the levels 
of DAG with aging are controversial, because some groups 
have demonstrated an increase [31], while others did not find 
any changes [18]. Thus, the increase of IP 3 as well as of DAG 
in the resting state with aging seem to corroborate this assump- 
tion. 
We assessed cell distribution and T cell stimulation-induced 
translocation f five PKC isozymes (cz, fl, 6, e and () by Western 
blots. All five PKC isotypes were present in T cells of young 
and elderly subjects. However, their distribution between the 
cytosolic and membrane fractions varied with the isozyme stud- 
ied and the age of the subjects. Of interest was the finding that 
in lymphocytes of elderly subjects PKC-g and -e were distrib- 
uted almost equally between the cytosolic and the membrane 
fractions whereas PKC-~z and -( were mainly found in the 
membrane fraction. The only exception was PKC-fl which was 
almost exclusively located in the cytosolic fraction of resting T
lymphocytes of elderly subjects. In the case of young subjects, 
PKC-~ was detected in the cytosol fraction of lymphocytes. 
However, the novel PKC ~ and e isoforms partitioned to some 
extent o the cytosol fraction in the absence of stimulation by 
agonists. It is noteworthy to mention that in the case of PKC-e 
of young subjects there is a decrease in the cytosol after stimu- 
lation but most of the isozyme does not translocate to the 
membrane (Table 2). Whether a degradation process occurs 
already during translocation r rapidly in the membrane needs 
further investigations. Cell distribution of PKC-~" which was 
found to be important in the particulate fraction of lympho- 
cytes of young subjects without appreciable r distribution after 
stimulation. Of interest PKC-( of elderly subjects apparently 
dissociated from the particulate fraction and moved to the 
cytosol. PKC-( has been already demonstrated in the mem- 
brane of other cell types in the resting state [32] and that raises 
the possibility that this 'reverse translocation' may occur in 
other cells. We can not offer a conclusive xplanation at this 
time. 
A redistribution f PKC to the membrane has been demon- 
strated in human platelets and in the soleus muscle of rats with 
aging [33,34]. Similar shifts in PKC isozymes distribution with 
development and aging have been demonstrated in cultured 
neonatal and adult ventricular myocytes [35]. However, our 
study is the first report showing an altered istribution of PKC 
isozymes in lymphocytes ofelderly subjects, associated with an 
altered translocation after anti-CD3 stimulation, except in the 
case of PKC-fl. These findings may be related to a chronic basal 
activation state of some PKC isozymes in elderly subjects. As 
a consequence anincreased binding to the intracellular receptor 
for protein kinase C (RACK) [36] may occur maintaining this 
translocation state. In addition, the calpain (Ca2+-dependent 
proteinases) activity, which may be responsible for membrane- 
associated ownregulation f PKCs [37], could be decreased 
with aging. Further investigations are obviously needed to as- 
sess these possibilities. 
It is widely accepted that the activation of cellular PKC 
results from the receptor-mediated translocation of inactive 
cytosolic enzyme to the lipid environment of the membrane. In
vitro studies on the association of purified PKC with phospho- 
lipid vesicles and inside-out erythrocytes have led to the sugges- 
tion that PKC may associate with the plasma membrane in an 
inactive, but primed state [38]. Thus, in principle, membrane 
PKC activity may be stimulated incells by activating the inac- 
tive form of the enzyme associated with membranes, a process 
not requiring the translocation of PKC from the cytosol. Re- 
cently, it has been demonstrated [39] that PKC indeed exists on 
the membrane ofa variety of cells and tissues in both an active 
and an inactive state and that activation of this pool of inactive 
membrane PKC may be an important step in many PKC- 
mediated cellular events [40,41]. Such a phenomenon may also 
occur in lymphocytes ofelderly subjects. Whatever is the exact 
cause, the decreased availability of cytosolic PKC as reported 
here may contribute to the diminished PKC-dependent re- 
sponses after anti-CD3 stimulation of human T lymphocytes 
with aging. 
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